VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum

This publication has 36 references indexed in Scilit:

• Human serum-resistant retroviral vector particles from galactosyl (α1–3) galactosyl containing nonprimate cell lines
  Gene Therapy, 1999
• Complement-Protected Amphotropic Retroviruses from Murine Packaging Cells
  Human Gene Therapy, 1999
• Lentiviral vectors and gene therapy
  Frontiers in Bioscience-Landmark, 1999
• Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
  Nature Genetics, 1997
• The α-Galactosyl Epitope: A Sugar Coating That Makes Viruses and Cells Unpalatable
  Cell, 1996
• Development of Amphotropic Murine Retrovirus Vectors Resistant to Inactivation by Human Serum
  Human Gene Therapy, 1996
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
  Science, 1996
• Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase
  Nature, 1996
• Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
  The Journal of Experimental Medicine, 1995
• The Effects of Human Serum and Cerebrospinal Fluid on Retroviral Vectors and Packaging Cell Lines
  Human Gene Therapy, 1995